SCHEMBL30445226

CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 2)

	gene	UniProt	supporting neighbours	confidence
▸	APLNR	P35414	5/20	0.73

▸	GHSR	Q92847	2/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29598921	0.92	APLNR (0.78)	APLNR
SCHEMBL29669783	0.92	APLNR (0.78)	APLNR
SCHEMBL30444899	0.91	APLNR (0.77)	APLNR
SCHEMBL30359270	0.90	APLNR (0.88)	APLNR
SCHEMBL30359267	0.90	APLNR (0.88)	APLNR
SCHEMBL29413125	0.89	APLNR (0.74)	APLNR
SCHEMBL31253160	0.89	APLNR (0.73)	APLNR
SCHEMBL29736716	0.88	APLNR (0.71)	APLNR
SCHEMBL21532854	0.87	APLNR (0.75)	APLNR
SCHEMBL30359273	0.87	APLNR (0.75)	APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230173076-A1	METABOLICALLY STABLE PEPTIDE ANALOGS	UNIV STRASBOURG (FR)	2023-06-08	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20230173076-A1	METABOLICALLY STABLE PEPTIDE ANALOGS	GPR119, GLP1R, GIPR	APLNR 115/4885GHSR 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.